Sabra Healthcare REIT (NASDAQ:SBRA) Stock Price Expected to Rise, UBS Group Analyst Says

Sabra Healthcare REIT (NASDAQ:SBRA) had its price target raised by research analysts at UBS Group from $20.00 to $22.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “neutral” rating on the real estate investment trust’s stock. UBS Group‘s price objective indicates a potential upside of 4.91% from the stock’s previous close.

Several other brokerages have also recently issued reports on SBRA. Weiss Ratings raised Sabra Healthcare REIT from a “hold (c)” rating to a “buy (b-)” rating in a research note on Tuesday, November 3rd. Robert W. Baird raised their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Wells Fargo & Company dropped their price target on Sabra Healthcare REIT from $23.00 to $21.00 and set an “overweight” rating on the stock in a research note on Monday, October 19th. Citizens Jmp upped their target price on Sabra Healthcare REIT from $23.00 to $25.00 and gave the company a “market outperform” rating in a research report on Wednesday, July 22nd. Finally, Raymond James Financial raised shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a report on Thursday, August 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, Sabra Healthcare REIT currently has a consensus rating of “Moderate Buy” and a consensus price target of $21.67.

Sabra Healthcare REIT Trading Down 1.6%

Shares of Sabra Healthcare REIT stock traded down $0.35 on Wednesday, reaching $20.97. The company had a trading volume of 1,761,851 shares, compared to its average volume of 2,688,708. Sabra Healthcare REIT has a 1 year low of $17.53 and a 1 year high of $22.77. The firm has a market cap of $5.49 billion, a price-to-earnings ratio of 74.90, a P/E/G ratio of 1.95 and a beta of 0.68. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.21 and a quick ratio of 1.21. The firm’s 50-day moving average price is $19.90 and its two-hundred day moving average price is $20.02.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its earnings results on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). Sabra Healthcare REIT had a return on equity of 2.55% and a net margin of 7.78%. The firm had revenue of $249.57 million during the quarter, compared to the consensus estimate of $236.64 million. During the same quarter last year, the business posted $0.38 EPS. Sabra Healthcare REIT’s revenue was up 31.4% compared to the same quarter last year. As a group, research analysts predict that Sabra Healthcare REIT will post 1.52 earnings per share for the current fiscal year.

Insider Activity at Sabra Healthcare REIT

In other news, CEO Richard Matros sold 200,000 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total value of $4,166,000.00. Following the transaction, the chief executive officer directly owned 1,657,686 shares of the company’s stock, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 1.09% of the company’s stock.

Institutional Investors Weigh In On Sabra Healthcare REIT

A number of institutional investors have recently made changes to their positions in SBRA. Rush Island Management LP purchased a new stake in Sabra Healthcare REIT during the first quarter worth about $30,735,000. William Blair Investment Management LLC acquired a new position in Sabra Healthcare REIT in the third quarter valued at $16,545,000. Russell Investments Group Ltd. raised its stake in shares of Sabra Healthcare REIT by 70.2% during the third quarter. Russell Investments Group Ltd. now owns 1,856,730 shares of the real estate investment trust’s stock worth $36,615,000 after purchasing an additional 765,527 shares during the last quarter. BROOKFIELD Corp ON purchased a new position in Sabra Healthcare REIT during the first quarter worth about $9,710,000. Finally, First Trust Advisors LP grew its holdings in Sabra Healthcare REIT by 99.4% during the first quarter. First Trust Advisors LP now owns 750,633 shares of the real estate investment trust’s stock worth $14,435,000 after acquiring an additional 374,202 shares during the period. 99.40% of the stock is currently owned by institutional investors and hedge funds.

About Sabra Healthcare REIT

Sabra Health Care REIT, Inc. is a real estate investment trust that owns and invests in properties used to provide healthcare and senior living services. Its portfolio includes skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals. Sabra generally leases its properties to healthcare and senior living operators, providing real estate that supports their services. The company’s properties are located in the United States and Canada.